2025
ICD-10-CM
Diagnosis
Code

C61 Malignant neoplasm of prostate

  • Billable
  • 2016–2025

C61 is a billable/specific diagnosis code from the 2025 ICD-10-CM used to classify the following condition: Malignant neoplasm of prostate.

Use additional code

  • Code, if applicable, to identify:

    • Hormone sensitivity status (Z19.1-Z19.2)

    • Rising PSA following treatment for malignant neoplasm of prostate (R97.21)

Type 1 excludes

  • Malignant neoplasm of seminal vesicle (C63.7)

Versions

  1. 2025

    No changes

  2. 2024

    No changes

  3. 2023

    Code changed

    • Use additional code

        • code to identify:
        • hormone sensitivity status (Z19.1-Z19.2)
        • rising PSA following treatment for malignant neoplasm of prostate (R97.21)
        • code, if applicable, to identify:
        • hormone sensitivity status (Z19.1-Z19.2)
        • rising PSA following treatment for malignant neoplasm of prostate (R97.21)
  4. 2022

    No changes

  5. 2021

    No changes

  6. 2020

    No changes

  7. 2019

    No changes

  8. 2018

    No changes

  9. 2017

    Code changed

    • Use additional code

        • code to identify:
        • hormone sensitivity status (Z19.1-Z19.2)
        • rising PSA following treatment for malignant neoplasm of prostate (R97.21)
  10. 2016

    New code